Aurora Cannabis Launches New CBD Lozenge in Canada, Developed with Vectura Fertin Pharma
Portfolio Pulse from Benzinga Newsdesk
Aurora Cannabis Inc. has launched a new CBD lozenge in Canada, developed in collaboration with Vectura Fertin Pharma. The product is available through Aurora's e-commerce platform, marking Vectura's first medical cannabis product in Canada.
September 09, 2024 | 11:08 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aurora Cannabis has launched a new CBD lozenge in Canada, developed with Vectura Fertin Pharma. This product launch could enhance Aurora's product offerings and market reach in the medical cannabis sector.
The launch of a new CBD product in collaboration with Vectura Fertin Pharma could positively impact Aurora's market position and sales in the medical cannabis sector. The product's availability on Aurora's e-commerce platform may increase customer reach and sales.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90